Variability in atherogenic lipoproteins and coronary artery disease progression-Reference-Cited by-同舟云学术

Variability in atherogenic lipoproteins and coronary artery disease progression

Published:2018-06-21 Issue:27 Volume:39 Page:2559-2561
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Alfonso Fernando¹,Rivero Fernando¹,Sánchez-Madrid Francisco²

Affiliation:

1. Department of Cardiology, Hospital Universitario de La Princesa, Madrid, Spain

2. Department of Immunology, Hospital Universitario de La Princesa, Madrid, CIBER Cardiovascular, Spain

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/39/27/2559/25161825/ehy348.pdf

Reference21 articles.

1. Intravascular ultrasound imaging of angiographically normal coronary segments in patients with coronary artery disease;Alfonso;Am Heart J,1994

2. Predictors and implications of residual plaque burden after coronary stenting: an intravascular ultrasound study;Alfonso;Am Heart J,2003

3. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial;Nissen;JAMA,2004

4. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease;Nissen;N Engl J Med,2005

5. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome;Nicholls;J Am Coll Cardiol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biological applications of near-infrared optical nanomaterials in atherosclerosis;Journal of Nanobiotechnology;2024-08-12

2. Differences in Cholesterol Metabolism, Hepato-Intestinal Aging, and Hepatic Endocrine Milieu in Rats as Affected by the Sex and Age;International Journal of Molecular Sciences;2023-08-10

3. Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome;International Urology and Nephrology;2023-01-17

4. The State of the Problem of Achieving Extremely Low LDL Levels;Current Pharmaceutical Design;2021-10

5. Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study;Scientific Reports;2021-04-13